Using AwareNet, we observed a reduction in the density of BLIMP1+ tumor cells, and of the immune cell subsets, CD8 and Tregs in posttreatment BM, compared with diagnostic samples from paired NDMM. This evidence concerns the gene CD8A and neoplasm.